JESSICA GARGUS: Open Payments
NPI 1255309506 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$442 in 22 payments from 7 companies in 2025. Trend: 2023 $654 · 2024 $510 · 2025 $442
Food & beverage: $442
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 9 | $150 |
| Alnylam Pharmaceuticals Inc. | 1 | $103 |
| Amgen Inc. | 4 | $66 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| Philips North America LLC | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $3 |
Products named: VERQUVO, AMVUTTRA, REPATHA, Kerendia, Extended Holter, LEQVIO, ENTRESTO, CAPVAXIVE.
Industry payments across KY — which companies pay providers there.
